8 Contradicted by research
Twin studies from Denmark demonstrate that identical twins with differing lifestyle habits (such as smoking, obesity, and sun exposure) exhibit substantially different physical aging rates.
"There are actually twin studies mostly from Denmark. Identical twins: one that goes and smokes and gets obese and goes in the sun, and they are much older-looking than their identical twin, essentially proving that the DNA is not the reason you age." (said at 0:35:34)
The Danish Longitudinal Study of Aging Twins did evaluate environmental determinants of perceived facial age and survival, but the speaker's specific statements invert key findings and misrepresent the genetic conclusions. First, in elderly Danish twins (age 70+), it was low BMI—not obesity—that was significantly associated with higher perceived facial age (older appearance), because facial volume loss accentuates wrinkles. Second, while smoking and sun exposure were associated with looking older, the study found that non-genetic/environmental factors accounted for approximately 40% of the variance in perceived age, with the remaining ~60% attributable to genetic factors. Thus, the evidence contradicts the claim that obesity makes twins look older in this cohort, as well as the assertion that these studies prove DNA is not why we age.
The global human population is projected to begin a steep decline by the year 2050.
"cuz by 2050 we're going to start going in a bad decline and earlier in many Western countries." (said at 0:57:02)
Major global demographic forecasting models do not project the global human population to begin declining by 2050. According to reference projections published in The Lancet (GBD/IHME), the global population is projected to continue growing until peaking in 2064 at approximately 9.73 billion before declining to 8.79 billion by 2100 (and the United Nations projects peak population even later, in the 2080s). While fertility rates are projected to fall below the replacement level (TFR < 2.1) in 151 countries by 2050, and several individual countries (such as Japan, Spain, and Italy) are projected to experience population decline earlier, the aggregate global population is not projected to start declining by 2050.
Fasting raises NAD levels in both humans and yeast.
"And so what we found was that when we fast the yeast or we fast a human, NAD levels go up again. So fasting raises NAD and makes the sirtuins young again, essentially." (said at 1:18:56)
The speaker's assertion that fasting/calorie restriction raises NAD+ levels in yeast is directly contradicted by published mechanistic studies from yeast longevity research (including work from the speaker's own field). In Saccharomyces cerevisiae, calorie restriction extends lifespan not by increasing NAD+ levels, but by upregulating PNC1 to deplete nicotinamide (an endogenous inhibitor of Sir2), while nuclear NAD+ levels actually decrease or remain unchanged (PMID: 14605207, PMID: 12736687). In humans, robust clinical trial evidence demonstrating that fasting raises tissue or whole-blood NAD+ levels is lacking.
Human clinical trials have demonstrated that sirtuin activation via NMN lowers body weight, reduces inflammation, and improves cholesterol levels.
"And we believe, and we have some evidence now in human clinical trials, that the sirtuins are imparting health benefits, reestablishing the epigenome, lowering body weight, improving inflammation, and even changing cholesterol levels in a positive way in humans." (said at 1:20:26)
The speaker claimed that human clinical trials show NMN/sirtuin activation lowers body weight, improves inflammation, and positively alters cholesterol levels. However, systematic reviews and meta-analyses of randomized controlled trials examining oral NMN supplementation in humans have found no statistically significant effects on body weight, BMI, lipid/cholesterol profiles, or glycemic parameters.
- contradicts: Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A System… (Current diabetes reports 2024) · cited 8x in the literature
"The random-effects meta-analyses indicated no significant benefit of NMN on fasting glucose, fasting insulin, glycated hemoglobin, homeostatic model assessment for insulin resistance and lipid profile. Based on the small number of RCTs involving mainly relatively healthy adults, short-term supplementation of NMN of 250-2000 mg/d did not show significantly positive impacts on glucose control and lipid profile." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - contradicts: NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review… (Ageing research reviews 2026) · cited 7x in the literature
"In humans, oral NR and NMN consistently demonstrated biochemical target engagement (circulating (plasma/whole blood) or cellular (e.g., PBMC) NAD-related metabolites) and were generally well tolerated over weeks to months; however, effects on functional, metabolic, vascular, and other healthspan-relevant outcomes were heterogeneous and often null or endpoint-specific." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - contradicts: Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation… (Nutrients 2026)
"No significant effects were observed on body weight, BMI, fasting glucose, HbA1c, lipid profiles, or systolic blood pressure." (abstract, results, passage verified)
pubmedfull study (doi)
In cellular biochemistry, two NMN molecules are put together to form NAD inside a cell.
"NMN is directly converted into NAD. You put two NMNs together, you get NAD in cell. We know this for a fact." (said at 1:20:01)
The speaker's claim that NAD is formed by putting two NMN molecules together is biochemically incorrect. Inside cells, nicotinamide adenine dinucleotide (NAD+) is synthesized by the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT), which conjugates one molecule of NMN with one molecule of ATP (adenosine triphosphate) to generate NAD+ and inorganic pyrophosphate (PPi). NAD is a dinucleotide composed of a nicotinamide nucleotide linked to an adenine nucleotide, not two nicotinamide mononucleotides joined together.
Spermidine was first discovered and crystallized in human semen by Antoni van Leeuwenhoek.
"Well, that's how it was discovered. It was crystallized by, I believe, Antoni van Leeuwenhoek, the one of the first microscopists and microbiologists." (said at 1:51:51)
Antoni van Leeuwenhoek did not discover or crystallize spermidine; in 1678, he observed and described crystals in human semen that were later identified as spermine (specifically spermine phosphate). Spermidine was isolated and characterized much later, in the 1920s by Dudley, Rosenheim, and colleagues. While both spermine and spermidine are related polyamines, the historical crystallization in semen by Leeuwenhoek is specifically the discovery of spermine.
Shading green tea plants prior to harvesting increases their chlorophyll and polyphenol content.
"the growers of those plants in Japan, typically, they shade the plants before they harvest. Shading the plants stresses them out. Plants need light. So they don't just make more chlorophyll, which produces the deep green color in the tea, but the polyphenols are super high." (said at 1:31:16)
The speaker bundles two assertions: that shading tea plants prior to harvest increases chlorophyll (accurate) and that it increases polyphenol content (contradicted). In tea cultivation (such as the production of tencha/matcha and gyokuro in Japan), pre-harvest shading stimulates chlorophyll and L-theanine accumulation while down-regulating flavonoid biosynthesis pathways driven by light and UV radiation. Consequently, shading significantly decreases major catechins and total polyphenol content compared to sun-grown tea leaves, reducing bitterness and astringency.
- contradicts: Biosynthesis of catechin components is differentially regulated in dark-treated tea (… (Plant physiology and biochemistry : PPB 2014) · cited 62x in the literature
"The vanillin assay showed that the dark-treated plants contained lower levels of total catechins than those grown under normal conditions." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Metabolomic analysis using ultra-performance liquid chromatography-quadrupole-time of flig… (PloS one 2014) · cited 141x in the literature
"Most flavonoid metabolites (mainly flavan-3-ols, flavonols and their glycosides) decreased significantly in the shading treatments, while the contents of chlorophyll, β-carotene, neoxanthin and free amino acids, caffeine, benzoic acid derivatives and phenylpropanoids increased." (abstract, results)
pubmedfull study (doi) - contradicts: Metabolite profiling and transcriptomic analyses reveal an essential role of UVR8-mediated… (BMC plant biology 2018) · cited 129x in the literature
"While shading enhanced chlorophyll accumulation, major catechins, including C, EC, GC and EGC, decreased significantly in tea buds throughout the whole shading period. The reduction of catechins and flavonols were consistent with the simultaneous down-regulation of biosynthetic genes and TFs associated with flavonoid biosynthesis." (abstract, results, passage verified)
pubmedfull study (doi)
Macular degeneration is the largest cause of blindness besides glaucoma.
"If they work, then we go on to macular degeneration, which is the largest cause of blindness besides glaucoma." (said at 2:08:27)
Global epidemiological data from the Global Burden of Disease (GBD) Study and the World Health Organization show that cataract is by far the leading cause of blindness worldwide, not glaucoma. In 2020, among adults aged 50 and older, the leading global causes of blindness were cataract (15.2 million cases), glaucoma (3.6 million cases), undercorrected refractive error (2.3 million cases), and age-related macular degeneration (1.8 million cases). In high-income countries, age-related macular degeneration is often the leading cause of irreversible blindness (surpassing glaucoma), rather than second to it.
- contradicts: Causes of vision loss worldwide, 1990-2010: a systematic analysis. (The Lancet. Global health 2013) · cited 1887x in the literature
"Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%)..." (abstract, results)
pubmedfull study (doi) - contradicts: Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence… (The Lancet. Global health 2021) · cited 3152x in the literature
"The leading global causes of blindness in those aged 50 years and older in 2020 were cataract (15·2 million cases [9% IU 12·7-18·0]), followed by glaucoma (3·6 million cases [2·8-4·4]), undercorrected refractive error (2·3 million cases [1·8-2·8]), age-related macular degeneration (1·8 million cases [1·3-2·4]), and diabetic retinopathy (0·86 million cases [0·59-1·23])." (abstract, results)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.